LifeMD, Inc. (NASDAQ:LFMD) Director Happy David Walters purchased 41,697 shares of the firm’s stock in a transaction dated Tuesday, September 14th. The stock was acquired at an average price of $7.19 per share, with a total value of $299,801.43. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
NASDAQ:LFMD traded up $0.74 during mid-day trading on Wednesday, hitting $7.45. 12,269 shares of the company traded hands, compared to its average volume of 1,007,116. The stock’s fifty day moving average price is $8.72 and its 200-day moving average price is $11.66. LifeMD, Inc. has a one year low of $5.05 and a one year high of $33.02. The firm has a market cap of $197.89 million, a price-to-earnings ratio of -1.33 and a beta of 0.65.
LifeMD (NASDAQ:LFMD) last released its quarterly earnings results on Thursday, August 12th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.45) by ($0.06). The business had revenue of $22.31 million during the quarter, compared to analyst estimates of $21.57 million.
A number of large investors have recently added to or reduced their stakes in the business. Ophir Asset Management Pty Ltd bought a new stake in LifeMD during the second quarter valued at about $11,860,000. Millennium Management LLC boosted its stake in shares of LifeMD by 27.6% in the second quarter. Millennium Management LLC now owns 949,215 shares of the company’s stock worth $11,182,000 after acquiring an additional 205,074 shares during the period. Vanguard Group Inc. boosted its stake in shares of LifeMD by 3.5% in the second quarter. Vanguard Group Inc. now owns 732,014 shares of the company’s stock worth $8,623,000 after acquiring an additional 24,920 shares during the period. BlackRock Inc. boosted its stake in shares of LifeMD by 18.2% in the second quarter. BlackRock Inc. now owns 419,511 shares of the company’s stock worth $4,941,000 after acquiring an additional 64,508 shares during the period. Finally, Atom Investors LP bought a new position in shares of LifeMD in the first quarter worth about $5,216,000. 25.56% of the stock is owned by institutional investors and hedge funds.
LifeMD Company Profile
LifeMD, Inc is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm’s network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States.
Featured Story: Why are percentage gainers important?
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.